-
公开(公告)号:JPH0525169A
公开(公告)日:1993-02-02
申请号:JP27172591
申请日:1991-07-19
Applicant: FUJISAWA PHARMACEUTICAL CO
Inventor: TAKASUGI HISASHI , NISHINO SHIGETAKA , INOUE ZENICHI
IPC: A61K31/435 , A61P1/04 , C07D471/04
Abstract: PURPOSE:To provide the subject novel compound useful as an antineoplasmic agent. CONSTITUTION:The objective compound of formula I (R is or lower alkyl; R is H, lower alkyl, halogen or acyl; R is H, lower alkyl, cyclo lower alkyl or lower alkenyl), for example, 5-(3,7-dimethyl-5,6,7,8-tetrahydroimidazo[1,2- a]pyridin-2-yl)-2-methylaminobenzoxazole. This compound can be obtained by catalytic reduction of a compound of formula II pref. using a catalyst such as platinum catalyst, palladium catalyst, nickel catalyst, cobalt catalyst, iron catalyst, or copper catalyst to subject it to hydrogenation.
-
公开(公告)号:JPS62252775A
公开(公告)日:1987-11-04
申请号:JP633487
申请日:1987-01-14
Applicant: FUJISAWA PHARMACEUTICAL CO
Inventor: TAKATANI TAKAO , TAKASUGI HISASHI , KUNO ATSUSHI , INOUE ZENICHI
IPC: A61K31/505 , A61P9/04 , C07D211/80 , C07D213/00 , C07D239/00 , C07D239/10 , C07D239/22 , C07D401/12
Abstract: NEW MATERIAL:The dihydropyrimidine derivative of formula I (R is H or together with A form a double bond in a ring; R is lower alkyl, lower alkenyl or lower alkynyl; R is lower alkyl or together with A form a double bond in a ring; R is lower alkyl; R is esterified carboxy or phosphonyl; R is H, nitro or lower alkoxy; R is lower alkoxy, lower alkynyloxy or nitro; either one of R and R together with A form a double bond in a ring) or its salt. USE:A medicine having strong cardiotonic activity and, nevertheless, rather decreasing the pulse rate and useful as a cardiotonic agent for the prevention and remedy of cardiopathy such as cardiac insufficiency. PREPARATION:The compound of formula I can be produced e.g. by reacting the compound of formula II (R is H, etc.) with the compound of formula III according to the reaction formula.
-
公开(公告)号:JPS5798288A
公开(公告)日:1982-06-18
申请号:JP17063381
申请日:1981-10-23
Applicant: FUJISAWA PHARMACEUTICAL CO
Inventor: TAKATANI TAKAO , INOUE ZENICHI , MURATA MASAYOSHI , TAKASUGI HISASHI
IPC: A61K31/545 , A61K31/546 , A61P31/04 , C07D501/38 , C07D501/46
Abstract: NEW MATERIAL:The cephem compound of formulaI(R is NH2 or protected amino; R is 2-6C alkyl) and its salt. EXAMPLE:7-[2-Ethoxyimino-2-(2-aminothiazol-4-yl)acetamido]-3-(1-pyridi niomethyl)-3-cephem-4-carboxylate(syn-isomer). USE:Antibacterial agent having high antibacterial activity against various bacteria including Gram-positive and Gram-negative bacteria. PROCESS:The compound of formulaIor its salt is prepared e.g. by reacting the compound of formula II or its reactive derivative or its salt with the compound of formula III or its reactive derivative or its salt.
-
公开(公告)号:JPH09278767A
公开(公告)日:1997-10-28
申请号:JP2356397
申请日:1997-02-06
Applicant: FUJISAWA PHARMACEUTICAL CO
Inventor: KUNO ATSUSHI , INOUE ZENICHI , YAMAZAKI HISAMI , TANAKA AKITO
IPC: C07D333/68 , A61K31/34 , A61K31/343 , A61K31/38 , A61K31/381 , A61K31/425 , A61K31/428 , A61K31/435 , A61P9/00 , A61P9/06 , A61P9/08 , A61P9/10 , A61P9/12 , A61P13/02 , A61P15/00 , A61P43/00 , C07D277/68 , C07D307/84 , C07D495/04 , C07D498/04 , C07D513/04 , C07D521/00
Abstract: PROBLEM TO BE SOLVED: To obtain a novel guanidine derivative which has a strong inhibitory action on Na /H exchange in cells, can be used in prevention and treatment of cardiovascular diseases, cerebrovascular diseases, arteriosclerosis and also can be used as a medicine for ischemic reperfusion disorder or organ protection in organ transplantation. SOLUTION: This novel guanidine derivative is represented by formula I [R is a (substituted) condensed heterocyclic ring group containing two to four N heteroatoms, a heterocyclic ring group containing 1-3 N heteroatoms and 1-2 O heteroatoms, a heterocyclic ring group containing 1-3 N heteroatoms and 1-2 S heteroatoms and (1-2 O heteroatoms), a heterocyclic group containing 1-2 O heteroatoms, a heterocyclic group containing 1-2 S heteroatoms, a heterocyclic group containing 1-2 O heteroatoms, and a heterocyclic group containing one O heteroatom and one or two S heteroatoms], typically [(benzo[b] thiophen-2-yl) carbonyl]guanidine methanesulfonate. The compound of formula I is obtained by reaction of a compound of the formula: R -CO-OH with guanidine of formula II.
-
公开(公告)号:JPH06321921A
公开(公告)日:1994-11-22
申请号:JP32305292
申请日:1992-12-02
Applicant: FUJISAWA PHARMACEUTICAL CO
Inventor: KATSURA YOSUKE , FUJI TETSUO , INOUE ZENICHI , TAKASUGI HISASHI
IPC: A61K31/425 , A61K31/426 , A61K31/44 , A61P1/00 , A61P1/04 , A61P43/00 , C07D277/20 , C07D277/38 , C07D277/42 , C07D277/48 , C07D417/12 , C07D417/14
Abstract: PURPOSE:To obtain a novel and useful thiazole derivative having a strong antiulcer action and a strong H2-receptor antagonistic action. CONSTITUTION:A compound of formula I [R is H, lower alkyl which may be appropriatily substituted; R is H, lower alkyl, lower alkoxy, halogen; A is lower alkylene; Q is CO-R (R is organic group), carbamidoyl which may be appropriately substituted; when Q is carbamidoyl, R is lower alkoxy] or its pharmaceutically permissible salts, for example, 4-(3- acetylaminomethylphenyl)-2[[(amino)(methylamino)methylene]amino]thiazole. This compound is obtained by reaction of a compound of formula II (X is acid residue) or its salt with a compound of formula III or its salt in a solvent.
-
公开(公告)号:JPH0578353A
公开(公告)日:1993-03-30
申请号:JP18593291
申请日:1991-02-01
Applicant: FUJISAWA PHARMACEUTICAL CO
Inventor: TAKASUGI HISASHI , KATSURA YOSUKE , INOUE ZENICHI , FUJI TETSUO
IPC: A61K31/425 , A61P31/04 , C07D417/04 , C07D417/14
Abstract: PURPOSE:To provide a new antibacterial agent having especially high antibacterial activity against Gram-negative bacteria. CONSTITUTION:The objective agent contains, as an active component, a compound of formula I [R and R are H, acyl, (halogen-containing) lower alkyl or together form a lower alkylene; R is H or lower alkyl; R is amino, acyl, acylamino, lower alkylisothioureido, heterocyclic amino, heterocyclic group or group of formula IV [(n) is 0 or 1; X is CH or N; R is H, cyano, nitro or acyl; R is H, lower alkyl, lower alkylthio, lower alkoxy or (substituted) amino]; A is lower alkylene, CONH or forms a heterocyclic group in the form of A-R ; Q is H or lower alkyl] or its salt, e.g. 4-(5-acetylaminomethylfuran-2- yl)-2--(diaminomethyleneamino)thiazole. The compound of formula I can be produced by reacting a compound of formula II (Z'' is acid residue) with a compound of formula III in a solvent.
-
公开(公告)号:JP2000001486A
公开(公告)日:2000-01-07
申请号:JP12937699
申请日:1999-05-11
Applicant: FUJISAWA PHARMACEUTICAL CO
Inventor: TAKENAKA KOHEI , INOUE ZENICHI , AKAHA ATSUSHI , MACHITANI KOJI , NAKAMURA TAKASHI
IPC: C07D333/28 , A61K31/00 , A61K31/165 , A61K31/166 , A61K31/38 , A61K31/381 , A61P3/00 , A61P3/06 , A61P9/00 , A61P9/10 , A61P13/00 , A61P13/12 , A61P43/00
Abstract: PROBLEM TO BE SOLVED: To obtain a new compound having strong inhibiting action on Na+/H+ exchange in a human or animal cell and having further high effect as a medicine such as preventing and therapeutic agent for cardiovascular diseases. SOLUTION: This compound is represented by formula I [R1 is a group of formula II or III (R5 and R6 are each H, a lower alkyl or the like; X is carbonyl or sulfonyl); R2 is an arylyl or heterocycle; (n) is 1-6] and its salt, e.g. [3-(2,5-dichlorothiophen-3-yl)-5-[2-(methylaminoethyl)- aminocarbonyl]benzoyl]guanidine dihydrochloride. The compound of formula I is obtained by reacting a compound of formula IV, its derivative or a salt thereof with a compound of formula V, its derivative or a salt thereof. The reaction is usually carried out in water and an organic solvent under cooling or under heating. Furthermore, when the compound of formula V is used in a form of a free acid or its salt, the reaction is preferably carried out in the presence of a condensing agent.
-
公开(公告)号:JPH01242589A
公开(公告)日:1989-09-27
申请号:JP6891388
申请日:1988-03-22
Applicant: FUJISAWA PHARMACEUTICAL CO
Inventor: TAKASUGI HISASHI , INOUE ZENICHI
IPC: C07D501/22
Abstract: NEW MATERIAL:A compound (salt) expressed by the formula (R is amino or aminoacyl; R is carboxyl or protected carboxyl). EXAMPLE:7-acetamide-3-vinyl-2-cephem-4-carboxylic acid p-nitrobenzyl ester. USE:An antibacterial agent against wide pathogenic fungi containing Gram-posi tive and Gram-negative bacteria. PREPARATION:For example, 7-acetamide-3-vinyl-3-cephem-4-carboxylic acid and p-nitrobenzyl chloride are added to dimethyl sulfoxide and reacted in the presence of triethylamine at 40-45 deg.C for 4.5hr. The reaction mixture is then poured into a large amount of water and the resultant precipitate is filtered and purified using the column chromatography, etc., thus obtaining the objective compound of the formula.
-
公开(公告)号:JPS63115874A
公开(公告)日:1988-05-20
申请号:JP13709487
申请日:1987-05-29
Applicant: FUJISAWA PHARMACEUTICAL CO
Inventor: TAKATANI TAKAO , INOUE ZENICHI , MURATA MASAYOSHI , TAKASUGI HISASHI
IPC: C07D257/04 , A61K31/545 , A61K31/546 , A61P31/04 , C07D501/18 , C07D501/36
Abstract: NEW MATERIAL:A compound expressed by formula I (R is tetrazolyl having a lower alkynyl; R is mercapto-protecting group or H) and salt thereof. EXAMPLE:2-(2-Propynyl)-2H-tetrazole-5-thiol. USE:An intermediate for antimicrobial agent cephalo compounds. PREPARATION:A compound expressed by formula II (R is tetrazolyl; R is mercapto-protecting group) is reacted with a compound expressed by formula III (Z is acid residue; A is lower alkynyl) in the presence of an organic or inorganic base, e.g. alkali metal carbonate or pyridine, in a solvent, e.g. DMF, etc., to afford the aimed substance.
-
公开(公告)号:JPH0272177A
公开(公告)日:1990-03-12
申请号:JP20880189
申请日:1989-08-11
Applicant: FUJISAWA PHARMACEUTICAL CO
Inventor: TAKASUGI HISASHI , KATSURA YOSUKE , INOUE ZENICHI , FUJI TETSUO
IPC: A61K31/425 , A61K31/44 , A61K31/505 , A61K31/54 , A61P1/04 , A61P43/00 , C07D417/04 , C07D417/14
Abstract: NEW MATERIAL:A compound expressed by formula I [R and R are H, alkyl which may have a substituent group (acyl or halogen) or mutually link to form alkylene; R is H or alkyl; R is NH2, acyl, acylamino, heterocyclic group or formula II (n is 0 or 1; X is CH or N; R is H, CN, NO2, etc., R is H, alkyl, alkylthio, etc.), etc.; A is alkylene or CONH or A-R is heterocyclic group: Q is H or alkyl] and salts thereof. EXAMPLE:4- [5-(2-Amino-2-sulfamoyliminoethyl)furan-2-yl] -2-(diaminomethyl- eneamino)thiazole. USE:Having antitumor and H2-receptor antagonistic activity and useful for treating gastritis, ulcer, reflux esophagitis, upper gastrointestinal hemorrhage, etc. PREPARATION:For example, a compound expressed by formula III (Z is acid residue) or salt thereof is reacted with a compound expressed by formula IV to afford the compound expressed by formula I.
-
-
-
-
-
-
-
-
-